L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Term ID

CHEBI:61564

Synonyms

L-Ala-gamma-D-Glu-mDAP
L-Ala-gamma-D-Glu-meso-Dap
L-ala-gamma-D-Glu-meso-diaminopimelic acid
L-alanyl-N-[(1R,5S)-5-amino-1,5-dicarboxypentyl]-D-glutamine
Tri-DAP

Definition

A tripeptide comprising L-alanyl, gamma-D-glutamyl and meso-diaminopimelic acid residues in a linear sequence. It is a breakdown product of bacterial peptidoglycan and a NOD1 agonist.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: tripeptide

tripeptide Show first 5 Terms
has_functional_parent: gamma-D-glutamyl-meso-diaminopimelic acid

gamma-D-glutamyl-meso-diaminopimelic acid Show first 5 Terms
has_role: NOD1 agonist

NOD1 agonist Show first 5 Terms
inverse is_conjugate_base_of: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-)

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-) Show first 5 Terms
is_conjugate_acid_of: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-)

L-alanyl-gamma-D-glutamyl-meso-diaminopimelate(1-) Show first 5 Terms

Phenotype

Phenotype resulting from L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Phenotype where environments contain L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Phenotype modified by environments containing L-alanyl-gamma-D-glutamyl-meso-diaminopimelic acid

Human Disease Model